• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行背景下精神药物面临的挑战]

[Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].

作者信息

Javelot H, Llorca P-M, Meyer G, Fossati P, Haffen E

机构信息

Établissement Public de Santé Alsace Nord, Brumath, France; Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.

CHU Clermont-Ferrand, EA 7280, Université Clermont Auvergne, France.

出版信息

Encephale. 2020 Jun;46(3S):S116-S118. doi: 10.1016/j.encep.2020.04.009. Epub 2020 Apr 23.

DOI:10.1016/j.encep.2020.04.009
PMID:32360037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177137/
Abstract

French recommendations have been proposed for psychotropics use and possible adaptations during the SARS-CoV-2 epidemic. Between uncertainties linked to the lack of data and speculations about possible benefits of psychotropics against the coronavirus, we propose here elements allowing to base the pharmacotherapeutic decisions potentially useful in Covid+ patients with psychiatric disorders.

摘要

法国已针对精神药物的使用以及在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情期间可能的调整提出了建议。在与数据缺乏相关的不确定性以及关于精神药物对冠状病毒可能益处的猜测之间，我们在此提出一些要素，以便为可能对患有精神疾病的新冠病毒阳性患者有用的药物治疗决策提供依据。

相似文献

1
[Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].[严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行背景下精神药物面临的挑战]
Encephale. 2020 Jun;46(3S):S116-S118. doi: 10.1016/j.encep.2020.04.009. Epub 2020 Apr 23.
2
[Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].[关于法国在新冠疫情期间精神药物及其对精神障碍患者适应性的信息]
Encephale. 2020 Jun;46(3S):S14-S34. doi: 10.1016/j.encep.2020.04.006. Epub 2020 May 4.
3
Interactions of recommended COVID-19 drugs with commonly used psychotropics.推荐的新冠病毒治疗药物与常用精神药物的相互作用。
Asian J Psychiatr. 2020 Aug;52:102173. doi: 10.1016/j.ajp.2020.102173. Epub 2020 May 21.
4
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用：恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
5
Psychopharmacology of COVID-19.新型冠状病毒肺炎的精神药理学。
Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18.
6
Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders.治疗 COVID-19 患者精神症状的关注点，无论患者是否患有精神障碍。
Br J Psychiatry. 2020 Jul;217(1):351. doi: 10.1192/bjp.2020.84.
7
Drug repositioning is an alternative for the treatment of coronavirus COVID-19.药物重定位是治疗冠状病毒 COVID-19 的一种替代方法。
Int J Antimicrob Agents. 2020 Jun;55(6):105969. doi: 10.1016/j.ijantimicag.2020.105969. Epub 2020 Apr 9.
8
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.新冠病毒疾病（COVID-19）患者使用羟氯喹的精神科影响
Indian J Pharmacol. 2020 May-Jun;52(3):229-231. doi: 10.4103/ijp.IJP_595_20. Epub 2020 Aug 4.
9
Rapid repurposing of drugs for COVID-19.用于治疗新冠肺炎的药物快速重新利用。
Science. 2020 May 22;368(6493):829-830. doi: 10.1126/science.abb9332. Epub 2020 May 8.
10
[Panic and pandemic: Review of the literature on the links between panic disorder and the SARS-CoV-2 epidemic].[恐慌与大流行：关于恐慌症与SARS-CoV-2疫情之间联系的文献综述]
Encephale. 2020 Jun;46(3S):S93-S98. doi: 10.1016/j.encep.2020.05.010. Epub 2020 May 21.

引用本文的文献

1
Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?美沙酮治疗阿片类药物使用障碍和 2019 年冠状病毒病感染患者安全吗？
J Addict Nurs. 2022;33(2):86-94. doi: 10.1097/JAN.0000000000000457.
2
Psychotropics and COVID-19: An analysis of safety and prophylaxis.精神药物与 COVID-19：安全性与预防分析。
Encephale. 2021 Dec;47(6):564-588. doi: 10.1016/j.encep.2021.08.002. Epub 2021 Sep 2.
3
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances.从精神活性物质预防 SARS-CoV-2 的药理学假说角度探讨。
Med Hypotheses. 2020 Nov;144:110025. doi: 10.1016/j.mehy.2020.110025. Epub 2020 Jun 23.
4
Panic and pandemic: Narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic.恐慌与大流行：对 SARS-CoV-2 大流行期间恐慌障碍的相关性和风险的文献进行的叙述性综述。
Encephale. 2021 Feb;47(1):38-42. doi: 10.1016/j.encep.2020.08.001. Epub 2020 Aug 10.
5
[Panic and pandemic: Review of the literature on the links between panic disorder and the SARS-CoV-2 epidemic].[恐慌与大流行：关于恐慌症与SARS-CoV-2疫情之间联系的文献综述]
Encephale. 2020 Jun;46(3S):S93-S98. doi: 10.1016/j.encep.2020.05.010. Epub 2020 May 21.

本文引用的文献

1
Immediate Impact of Coronavirus Disease 2019 on Electroconvulsive Therapy Practice.2019冠状病毒病对电休克治疗实践的即时影响。
J ECT. 2020 Jun;36(2):86-87. doi: 10.1097/YCT.0000000000000688.
2
[Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].[关于法国在新冠疫情期间精神药物及其对精神障碍患者适应性的信息]
Encephale. 2020 Jun;46(3S):S14-S34. doi: 10.1016/j.encep.2020.04.006. Epub 2020 May 4.
3
[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].[法国新冠疫情期间的心理健康护理保障：一篇叙述性综述]
Encephale. 2020 Jun;46(3S):S3-S13. doi: 10.1016/j.encep.2020.03.001. Epub 2020 Apr 2.
4
Consensus statement on the use of clozapine during the COVID-19 pandemic.关于在2019冠状病毒病大流行期间使用氯氮平的共识声明。
J Psychiatry Neurosci. 2020 May 1;45(3):222-223. doi: 10.1503/jpn.200061.
5
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒（2019-nCoV/SARS-CoV-2）药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
6
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China.中国民众在 2019 年冠状病毒病（COVID-19）疫情初期的即时心理反应及相关因素。
Int J Environ Res Public Health. 2020 Mar 6;17(5):1729. doi: 10.3390/ijerph17051729.
7
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
8
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics.与其他第二代抗精神病药物相比，使用氯氮平治疗时肺炎可能更常见，且致死率更高。
World Psychiatry. 2020 Feb;19(1):120-121. doi: 10.1002/wps.20707.
9
Mirtazapine for chronic breathlessness? A review of mechanistic insights and therapeutic potential.米氮平治疗慢性呼吸困难？对其潜在治疗机制和治疗作用的综述。
Expert Rev Respir Med. 2019 Feb;13(2):173-180. doi: 10.1080/17476348.2019.1563486. Epub 2018 Dec 30.
10
Antipsychotic drug use and pneumonia: Systematic review and meta-analysis.抗精神病药物的使用与肺炎：系统评价和荟萃分析。
J Psychopharmacol. 2018 Nov;32(11):1167-1181. doi: 10.1177/0269881118795333. Epub 2018 Oct 18.